329 related articles for article (PubMed ID: 24628543)
1. Inhibitor eradication with rituximab in haemophilia: where do we stand?
Franchini M; Mannucci PM
Br J Haematol; 2014 Jun; 165(5):600-8. PubMed ID: 24628543
[TBL] [Abstract][Full Text] [Related]
2. Rituximab for adolescents with haemophilia and high titre inhibitors.
Fox RA; Neufeld EJ; Bennett CM
Haemophilia; 2006 May; 12(3):218-22. PubMed ID: 16643204
[TBL] [Abstract][Full Text] [Related]
3. Switching haemophilia products and inhibitor risk: a United States' perspective.
Nance D; Rodgers GM
Eur J Haematol; 2015 Apr; 94(4):283. PubMed ID: 25800968
[No Abstract] [Full Text] [Related]
4. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation.
Hay CR; Brown S; Collins PW; Keeling DM; Liesner R
Br J Haematol; 2006 Jun; 133(6):591-605. PubMed ID: 16704433
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.
Collins PW; Chalmers E; Hart DP; Liesner R; Rangarajan S; Talks K; Williams M; Hay CR;
Br J Haematol; 2013 Jan; 160(2):153-70. PubMed ID: 23157203
[No Abstract] [Full Text] [Related]
6. An analysis of factors affecting the incidence of inhibitor formation in patients with congenital haemophilia in Japan.
Shirahata A; Fukutake K; Higasa S; Mimaya J; Oka T; Shima M; Takamatsu J; Taki M; Taneichi M; Yoshioka A;
Haemophilia; 2011 Sep; 17(5):771-6. PubMed ID: 21682824
[TBL] [Abstract][Full Text] [Related]
7. Immunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B--a systematic literature review.
Laros-van Gorkom BA; Falaise C; Astermark J
Eur J Haematol Suppl; 2014 Aug; 76():26-38. PubMed ID: 24957105
[TBL] [Abstract][Full Text] [Related]
8. The reversal of inhibitors in congenital hemophilia.
DeFrates SR; McDonagh KT; Adams VR
Pharmacotherapy; 2013 Feb; 33(2):157-64. PubMed ID: 23355059
[TBL] [Abstract][Full Text] [Related]
9. Successful response to rituximab in two cases of acquired haemophilia refractory to standard-therapy.
Machado P; Raya JM; Martín T; Morabito L; Brito ML; Rodríguez-Martín JM
Int J Hematol; 2008 Jun; 87(5):545-549. PubMed ID: 18414981
[TBL] [Abstract][Full Text] [Related]
10. Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia.
Mathias M; Khair K; Hann I; Liesner R
Br J Haematol; 2004 May; 125(3):366-8. PubMed ID: 15086418
[TBL] [Abstract][Full Text] [Related]
11. Rituximab for treating inhibitors in people with inherited severe hemophilia.
Liu Y; Zhang L; Santoro C; Song J; Rodriguez A; Wang L
Cochrane Database Syst Rev; 2015 Apr; (4):CD010810. PubMed ID: 25841099
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of propagation of coagulation (factors VIII, IX and XI): a review of current therapeutic practice.
Franchini M; Mannucci PM
Br J Clin Pharmacol; 2011 Oct; 72(4):553-62. PubMed ID: 21204915
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor treatment by rituximab in congenital haemophilia A - Two case reports.
Streif W; Escuriola Ettingshausen C; Linde R; Kropshofer G; Zimmerhackl LB; Kreuz W
Hamostaseologie; 2009 May; 29(2):151-4. PubMed ID: 19404522
[TBL] [Abstract][Full Text] [Related]
14. How to manage invasive procedures in children with haemophilia.
Ljung RC; Knobe K
Br J Haematol; 2012 Jun; 157(5):519-28. PubMed ID: 22390160
[TBL] [Abstract][Full Text] [Related]
15. Immune tolerance with rituximab in congenital haemophilia with inhibitors: a systematic literature review based on individual patients' analysis.
Franchini M; Mengoli C; Lippi G; Targher G; Montagnana M; Salvagno GL; Zaffanello M; Cruciani M
Haemophilia; 2008 Sep; 14(5):903-12. PubMed ID: 18671801
[TBL] [Abstract][Full Text] [Related]
16. The management of hemophilia patients with inhibitors.
Nilsson IM
Transfus Med Rev; 1992 Oct; 6(4):285-93. PubMed ID: 1421831
[No Abstract] [Full Text] [Related]
17. Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors.
Astermark J; Morado M; Rocino A; van den Berg HM; von Depka M; Gringeri A; Mantovani L; Garrido RP; Schiavoni M; Villar A; Windyga J;
Haemophilia; 2006 Jul; 12(4):363-71. PubMed ID: 16834735
[TBL] [Abstract][Full Text] [Related]
18. The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A.
D'arena G; Grandone E; Di Minno MN; Musto P; Di Minno G
Blood Transfus; 2016 May; 14(2):255-61. PubMed ID: 26509821
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment with rituximab in an elderly patient with acquired factor VIII inhibitor.
Cretel E; Jean R; Chiche L; Durand JM
Geriatr Gerontol Int; 2009 Jun; 9(2):197-9. PubMed ID: 19490140
[TBL] [Abstract][Full Text] [Related]
20. Successful eradication of inhibitor of late recurrence and other high risk prognostic factors in a patient with severe haemophilia A.
Ranta S; Koskinen S; Mäkipernaa A
Haemophilia; 2011 Sep; 17(5):e833-4. PubMed ID: 21624011
[No Abstract] [Full Text] [Related]
[Next] [New Search]
